References
Filters: Author is Zeuzem, S [Clear All Filters]
Sofosbuvir and ribavirin in HCV genotypes 2 and 3. N Engl J Med. 2014;370:1993-2001.
. Glecaprevir-pibrentasvir for 8 or 12 weeks in HCV genotype 1 or 3 Infection. N Engl J Med. 2018;378(4):354-369. doi:10.1056/NEJMoa1702417.
.